Interestingly, the co-expression of certain antibodies—particularly anti-CCAR1 (cell division cycle and apoptosis regulator 1) alongside anti-TIF1γ—may reduce cancer risk to levels comparable to the general population [24]. The gene discussed is CCAR1; the disease is cancer.